Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter

American Journal of Pathology

Volumn 168, Issue 5, 2006, Pages 1654-1665

  Raimondi, Ana R ^a   Vitale Cross, Lynn ^a   Amornphimoltham, Panomwat ^a   Gutkind, J Silvio ^a   Molinolo, Alfredo ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SALIVARY GLAND; SALIVARY GLAND CARCINOMA;

EID: 33646499905     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050847     Document Type: Article

References (34)

1. Speight PM, Barrett AW: Salivary gland tumours. Oral Dis 2002, 8:229-240
2. Dardick I. Color Atlas/Text of Salivary Gland Tumor Pathology, New York, Igaku-Shoin Medical Publisher, Inc., 1996
3. Histological Typing of Salivary Gland Tumours. World Health Organization International histological classification of tumours, New York, TELOS, Springer-Verlag, 1991
4. Ellis GL, Auclair PL: Atlas of tumor pathology. Tumors of the salivary glands, Washington, DC, Armed Forces Institute of Pathology, 1996, p 31
5. Ide F, Suka N, Kitada M, Sakashita H, Kusama K, Ishikawa T: Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor. Cancer Lett 2004, 214:35-41
6. Azuma M, Tamatani T, Kasai Y, Sato M: Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori- mutant deoxyribonucleic acid. Lab Invest 1993, 69:24-42
7. Espinal EG, Ubios AM, Cabrini RL: Salivary gland tumors induced by 32P. J Oral Pathol 1984, 13:686-691
8. Dardick I, Ho J, Paulus M, Mellon PL, Mirels L: Submandibular gland adenocarcinoma of intercalated duct origin in Smgb-Tag mice. Lab Invest 2000, 80:1657-1670
9. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988, 55:619-625
10. Jhappan C, Gallahan D, Stahle C, Chu E, Smith GH, Merlino G, Callahan R: Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev 1992, 6:345-355
11. Daphna-Iken D, Shankar DB, Lawshe, Ornitz DM, Shackleford GM, MacArthur CA: MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 1998, 17:2711-2717
12. Dardick I, Burford-Mason AP, Garlick DS, Carney WP: The pathobiology of salivary gland. II. Morphological evaluation of acinic cell carcinomas in the parotid gland of male transgenic (MMTV/v-Ha-ras) mice as a model for human tumours. Virchows Arch A Pathol Anat Histopathol 1992, 421:105-113
13. Rodenhuis S: ras and human tumors. Semin Cancer Biol 1992, 3:241-247
14. Milasin J, Pujic N, Dedovic N, Gavric M, Vranik V, Petrovic V, Minic A: H-ras gene mutations in salivary gland pleomorphic adenomas. Int J Oral Maxillofac Surg 1993, 22:359-361
15. Stenman G, Sandros J, Mark J, Nordkvist A: High p21 RAS expression levels correlate with chromosome 8 rearrangements in benign human mixed salivary gland tumors. Genes Chromosomes Cancer 1989, 1:59-66
16. Zachos G, Spandidos DA: Expression of ras proto-oncogenes: regulation and implications in the development of human tumors. Crit Rev Oncol Hematol 1997, 26:65-75
17. van Halteren HK, Top B, Mooi WJ, Balm AJ, Rodenhuis S: Association of H-ras mutations with adenocarcinomas of the parotid gland. Int J Cancer 1994, 57:362-364
18. Andres AC, Schonenberger CA, Groner B, Hennighausen L, LeMeur M, Gerlinger P: Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci USA 1987, 84:1299-1303
19. Schaffner DL, Barrios R, Shaker MR, Rajagopalan S, Huang SL, Tindall DJ, Young CY, Overbeek PA, Lebovitz RM, Lieberman MW: Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms. Lab Invest 1995, 72:283-290
20. Vitale-Cross L, Amornphimoltham P, Fisher G, Molinolo AA, Gutkind JS: Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 2004, 64:8804-8807
21. Ramirez A, Bravo A, Jorcano JL, Vidal M: Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 1994, 58:53-64
22. Robbins & Cotran Pathologic Basis of Disease, Philadelphia, W. B. Saunders, 2004 (hardcover)
23. The Staff of the Jackson Laboratory. Biology of the Laboratory Mouse, Dover Publications, Inc., New York, 1981
24. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P: Coexpression of MMTV/v-Ha-ras and MMTV/c-myo genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 1987, 49:465-475
25. Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB: Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ 1995, 6:737-748
26. Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX: Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis. Oncogene 2001, 20:1445-1454
27. Miyamoto S, Guzman RC, Osborn RC, Nandi S: Neoplastic transformation of mouse mammary epithelial cells by in vitro exposure to N-methyl-N-nitrosourea. Proc Natl Acad Sci USA 1988, 85:477-481
28. Pazos P, Lanari C, Elizalde P, Montecchia F, Charreau EH, Molinolo AA: Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice. Carcinogenesis 1998, 19:529-531
29. Frank SA, Nowak MA: Cell biology: developmental predisposition to cancer. Nature 2003, 422:494
30. Bilal H, Handra-Luca A, Bertrand JC, Fouret PJ: P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 2003, 51:133-139
31. Seethala RR, Livolsi VA, Zhang PJ, Pasha TL, Baloch ZW: Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 2005, 27:696-702
32. Foschini MP, Gaiba A, Cocchi R, Pennesi MG, Gatto MR, Frezza GP, Pession A: Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 2004, 444:332-339
33. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC: Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 2003, 443:122-132
34. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998, 2:305-316